home / stock / adag / adag quote
Last: | $2.36 |
---|---|
Change Percent: | -1.26% |
Open: | $2.44 |
Close: | $2.39 |
High: | $2.47 |
Low: | $2.22 |
Volume: | 27,610 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.36 | $2.44 | $2.39 | $2.47 | $2.22 | 27,610 | 04-29-2024 |
$2.39 | $2.35 | $2.39 | $2.58 | $2.33 | 24,118 | 04-26-2024 |
$2.35 | $2.68 | $2.35 | $2.7708 | $2.32 | 39,920 | 04-25-2024 |
$2.75 | $2.75 | $2.75 | $2.75 | $2.75 | 744 | 04-24-2024 |
$2.65 | $2.64 | $2.65 | $2.75 | $2.64 | 8,101 | 04-23-2024 |
$2.73 | $2.57 | $2.73 | $2.73 | $2.57 | 1,390 | 04-22-2024 |
$2.64 | $2.63 | $2.64 | $2.64 | $2.5145 | 5,364 | 04-19-2024 |
$2.64 | $2.639 | $2.64 | $2.64 | $2.5148 | 1,778 | 04-18-2024 |
$2.53 | $2.62 | $2.53 | $2.7 | $2.5001 | 11,375 | 04-17-2024 |
$2.7 | $2.6001 | $2.7 | $2.72 | $2.6001 | 5,813 | 04-16-2024 |
$2.6 | $2.67 | $2.6 | $2.72 | $2.6 | 8,465 | 04-15-2024 |
$2.644 | $2.8975 | $2.644 | $3.02 | $2.62 | 17,529 | 04-12-2024 |
$2.82 | $2.87 | $2.82 | $2.9009 | $2.82 | 2,804 | 04-11-2024 |
$2.99 | $2.98 | $2.99 | $3.14 | $2.8 | 7,026 | 04-10-2024 |
$2.99 | $2.8939 | $2.99 | $3.06 | $2.86 | 9,248 | 04-09-2024 |
$2.83 | $2.893 | $2.83 | $3.08 | $2.83 | 6,978 | 04-08-2024 |
$2.85 | $3.0499 | $2.85 | $3.0499 | $2.8318 | 14,819 | 04-05-2024 |
$3.05 | $2.83 | $3.05 | $3.45 | $2.82 | 42,656 | 04-04-2024 |
$2.9 | $3.04 | $2.9 | $3.04 | $2.86 | 9,141 | 04-03-2024 |
$3 | $3.24 | $3 | $3.24 | $2.81 | 9,728 | 04-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Adagene Inc. Company Name:
ADAG Stock Symbol:
NASDAQ Market:
BioHarvest Sciences Inc (CNVCF) is expected to report for quarter end 2023-12-31 QS Energy Inc (QSEP) is expected to report for Q4 2023 NKGen Biotech Inc. (NKGN) is expected to report for Q4 2023 Cal-Maine Foods Inc. (CALM) is expected to report for Q3 2024 Davide Campari (DVDCF) ...
- Data for masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) highlight best-in-class therapeutic index and demonstrate clinical benefits in metastatic microsatellite-stable (MSS) colorectal cancer (CRC) with higher, more frequent and repeat dosing of anti-CTLA-4 therapy in com...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...